INBS logo

INTELLIGENT BIO SOLUTIONS IN

INBSNASDAQ
๐Ÿ† #4984 by market capUS Equity
$1.67โ–ผ $0.04 (โˆ’2.34%)
Market closed ยท at close
๐Ÿ””
Track INBS
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 2.3%
7dโ–ผ 2.3%
14dโ–ฒ 18.9%
30dโ–ฒ 1.2%
ytdโ–ผ 82.4%
1yโ–ผ 83.1%
๐ŸฆMarket Cap
$6M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
38.1%
High Growth
๐Ÿ“ŠGross Margin
48.6%
Healthy
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
1.3x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$1.67 โ€“ $1.68
52-Week Range
$1.35 โ€“ $24.90
Volume (shares)
429
Avg Volume (shares)
โ€”
Shares Outstanding
3.3M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
$4M
Last Q Revenue
$1M
P/E Ratio
โ€”
P/S Ratio
1.3x
EPS (TTM)
$-9.66
Dividend Yield
โ€”
INBS logo

INTELLIGENT BIO SOLUTIONS IN

INBS
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About INTELLIGENT BIO SOLUTIONS IN

Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.